A detailed history of Ashton Thomas Private Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 29,831 shares of ABBV stock, worth $5.46 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
29,831
Previous 29,139 2.37%
Holding current value
$5.46 Million
Previous $5 Billion 17.87%
% of portfolio
0.31%
Previous 0.27%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $113,377 - $137,936
692 Added 2.37%
29,831 $5.89 Billion
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $251,998 - $294,277
1,628 Added 5.92%
29,139 $5 Billion
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $521,812 - $594,556
3,265 Added 13.47%
27,511 $5.01 Billion
Q4 2023

Apr 19, 2024

SELL
$137.6 - $154.97 $23,942 - $26,964
-174 Reduced 0.71%
24,246 $3.76 Billion
Q3 2023

Apr 19, 2024

BUY
$133.59 - $154.65 $1.11 Million - $1.28 Million
8,295 Added 51.44%
24,420 $3.64 Billion
Q2 2023

Apr 22, 2024

BUY
$132.51 - $164.9 $995,945 - $1.24 Million
7,516 Added 45.3%
24,108 $3.25 Billion
Q1 2023

Apr 22, 2024

SELL
$144.61 - $166.54 $1.58 Million - $1.82 Million
-10,919 Reduced 39.69%
16,592 $2.64 Billion
Q4 2022

Apr 19, 2024

SELL
$138.31 - $165.87 $1.31 Million - $1.58 Million
-9,497 Reduced 37.07%
16,125 $2.61 Billion
Q3 2022

Apr 19, 2024

BUY
$134.21 - $153.93 $961,614 - $1.1 Million
7,165 Added 38.82%
25,622 $3.44 Billion
Q2 2022

Apr 19, 2024

BUY
$137.62 - $174.96 $644,199 - $818,987
4,681 Added 33.98%
18,457 $2.83 Billion
Q1 2022

Apr 19, 2024

BUY
$131.98 - $163.75 $412,041 - $511,227
3,122 Added 29.3%
13,776 $2.23 Billion
Q4 2021

Apr 19, 2024

BUY
$107.43 - $135.93 $239,568 - $303,123
2,230 Added 26.47%
10,654 $1.44 Billion
Q3 2021

Apr 19, 2024

SELL
$106.4 - $120.78 $143,640 - $163,053
-1,350 Reduced 13.81%
8,424 $909 Million
Q2 2021

Apr 19, 2024

BUY
$105.21 - $117.21 $32,509 - $36,217
309 Added 3.26%
9,774 $1.1 Billion
Q1 2021

Apr 19, 2024

SELL
$102.3 - $112.62 $374,724 - $412,527
-3,663 Reduced 27.9%
9,465 $1.02 Billion
Q4 2020

Apr 19, 2024

SELL
$80.49 - $108.67 $365,746 - $493,796
-4,544 Reduced 25.71%
13,128 $1.41 Billion
Q3 2020

Apr 19, 2024

SELL
$85.91 - $100.83 $417,264 - $489,731
-4,857 Reduced 21.56%
17,672 $1.55 Billion
Q2 2020

Apr 19, 2024

BUY
$73.37 - $98.18 $389,594 - $521,335
5,310 Added 30.84%
22,529 $2.21 Billion
Q1 2020

Apr 19, 2024

BUY
$64.5 - $97.79 $1.11 Million - $1.68 Million
17,219 New
17,219 $1.31 Billion
Q2 2019

Apr 19, 2024

SELL
$65.7 - $83.98 $165,366 - $211,377
-2,517 Closed
0 $0
Q1 2019

Apr 19, 2024

BUY
$77.14 - $90.79 $194,161 - $228,518
2,517 New
2,517 $203 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ashton Thomas Private Wealth, LLC Portfolio

Follow Ashton Thomas Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.